| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9646 |
| Human Intestinal Absorption | HIA+ | 0.7487 |
| Caco-2 Permeability | Caco2- | 0.6267 |
| P-glycoprotein Substrate | Non-substrate | 0.9137 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9194 |
| Non-inhibitor | 0.9904 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9521 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5257 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8775 |
| CYP450 2D6 Substrate | Non-substrate | 0.8213 |
| CYP450 3A4 Substrate | Non-substrate | 0.7007 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7768 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7601 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9115 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7548 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9759 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9577 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7988 |
| Non-inhibitor | 0.9446 |
| AMES Toxicity | Non AMES toxic | 0.5773 |
| Carcinogens | Carcinogens | 0.8111 |
| Fish Toxicity | Low FHMT | 0.6436 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.7516 |
| Honey Bee Toxicity | High HBT | 0.7865 |
| Biodegradation | Ready biodegradable | 0.9430 |
| Acute Oral Toxicity | III | 0.6069 |
| Carcinogenicity (Three-class) | Non-required | 0.6624 |